The effect of gentian violet on virulent properties of Candida albicans

Mycopathologia

Volumn 169, Issue 4, 2010, Pages 279-285

  Ying, Su ^a   Qing, Sun ^a   Chunyang, Li ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Candida albicans; Gentian violet; Virulence factors

Indexed keywords

ANTIFUNGAL AGENT; CRYSTAL VIOLET; FUNGAL PROTEIN; PEPTIDE HYDROLASE; PHOSPHOLIPASE;

ARTICLE; CANDIDA ALBICANS; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; PATHOGENICITY; VIRULENCE;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; FUNGAL PROTEINS; GENTIAN VIOLET; HUMANS; PEPTIDE HYDROLASES; PHOSPHOLIPASES; VIRULENCE;

CANDIDA ALBICANS; GENTIANA;

EID: 77952675616     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-009-9258-9     Document Type: Article

References (41)

1. van Meter F, Gallo JW, Garcia-Rojas G, et al. A study of oral candidiasis in HIV-positive patients. J Dent Hyg. 1994; 68: 30-4.
2. Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 1998; 178: 203-11.
3. Fotos PG, Vincent SD, Hellstein JW. Oral candidiasis: clinical, historical, and therapeutic features of 100 cases. Oral Surg Med Oral Pathol. 1992; 74: 41-9.
4. Kadir T, Uygun B, Akyuz S. Prevalence of Candida species in Turkish children: relationship between dietary intake and carriage. Arch Oral Biol. 2005; 50: 33-7.
5. Docampo R, Moreno SN. The metabolism and mode of action of gentian violet. Drug Metab Rev. 1990; 22: 161-78.
6. Simon C, Tabrizi SA. On the in vitro sensitivity of Candida albicans to nystatin, trichomycin, amphotericin B and gentian violet. Med Welt. 1967; 37: 2164-8.
7. Tolba MK, Saleh AM. Studies on the mechanism of fungicidal action of crystal violet on mycelial felts of Fusarium culmorum. Arch Mikrobiol. 1963; 47: 201-6.
8. Barrett-Bee K, Hayes Y, Wilson RG. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol. 1985; 131: 1217-21.
9. Sanglard D, Hube B, Monod M, et al. A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect Immun. 1997; 65: 3539-46.
10. Hube B, Sanglard D, Odds FC, et al. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect Immun. 1997; 65: 3529-38.
11. Leidich SD, Ibrahim AS, Fu Y, et al. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem. 1998; 273: 26078-86.
12. Bahn YS, Sundstrom P. CAP1, an adenylate cyclise associated protein gene, regulates bud-hypha transitions, filamentous growth and cyclic AMP levels and is required for virulence of Candida albicans. J Bacteriol. 2001; 183: 3211-23.
13. Rocha CR, Schroppel K, Harcus D, et al. Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogenic fungus Candida albicans. Mol Biol Cell. 2001; 12: 3631-43.
14. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia. 1982; 20: 7-14.
15. De Bernardis F, Chiani P, Ciccozzi M, et al. Elevated aspartyl proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect Immun. 1996; 64: 466-71.
16. Ellepola ANB, Samaranayake LP. The effect of brief exposure to sub-therapeutic concentrations of chlorhexidine gluconate on the germ tube formation of oral Candida albicans and its relationship to post-antifungal effect. Oral Dis. 2000; 6: 166-71.
17. McDonald PJ, Craig WA, Kunin CM. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J Infect Dis. 1977; 135: 217-23.
18. Ghannoum MA, Filler SG, Ibrahim AS, et al. Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B. Antimicrob Agents Chemother. 1992; 36: 2239-44.
19. Ombrella AM, Racca L, Ramos L. Proteases and phospholipases activities of Candida albicans isolated from vaginal secretions with different pH value. Rev Iberoam Micol. 2008; 25: 12-6.
20. Oksuz S, Sahin I, Yildirim M, Gulcan A, et al. Phospholipase and proteinase activities in different Candida species isolated from anatomically distinct sites of healthy adults. Jpn J Infect Dis. 2007; 60: 280-3.
21. Ribeiro MA, Miranda AE, Gambale W, et al. Prevalence and exoenzyme secretion by Candida albicans isolates from oral and vaginal mucosas of HIV-infected women. Mycopathologia. 2004; 157: 255-61.
22. Gumru B, Kadir T, Uygun-Can B, et al. Distribution and phospholipase activity of Candida species in different denture stomatitis types. Mycopathologia. 2006; 162: 389-94.
23. Arai R, Sagita T, Nishikawa A. The anthracycline antitumor agents doxorubicin and daunorubicin reduce the activity of Candida albicans phospholipase B. Microbiol Immunol. 2004; 48: 665-7.
24. Mayr A, Hinterberger G, Dierich MP, et al. Interaction of serotonin with Candida albicans selectively attenuates fungal virulence in vitro. Int J Antimicrob Agents. 2005; 26: 335-7.
25. Willis AM, Coulter WA, Fulton CR, et al. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 91: 317-21.
26. Anil S, Samaranayake LP. Brief exposure to antimycotics reduces the extracellular phospholipase activity of Candida albicans and Candida tropicalis. Chemotherapy. 2003; 49: 243-7.
27. Lyon JP, de Resende MA. Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102: 632-8.
28. Darwazeh AM, Lamey PJ, MacFarlane TW, et al. The effect of exposure to chlorhexidine gluconate in vitro and in vivo on in vitro adhesion of Candida albicans to buccal epithelial cells from diabetic and non-diabetic subjects. J Oral Pathol Med. 1994; 23: 130-2.
29. Pizzo G, Giuliana D, Milici ME. Effect of antimicrobial mouthrinses on the in vitro adhesion of Candida albicans to human buccal epithelial cells. Clin Oral Investing. 2001; 5: 172-6.
30. Kadir T, Gumru B, Uygun-Can B. Phospholipase activity of Candida albicans isolates from patients with denture stomatitis: the influence of chlorhexidine gluconate on phospholipase production. Arch Oral Biol. 2007; 52: 691-6.
31. Traboulsi RS, Mukherjee PK, Ghannoum MA. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients. Int J Antimicrob Agents. 2008; 31: 272-6.
32. Nyst MJ, Perriens JH, Kimputu L, Lumbila M, et al. Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients. Ann Soc Belg Med Trop. 1992; 72: 45-52.
33. Franz R, Kelly SL, Lamb DC, et al. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother. 1998; 42: 3065-72.
34. Lewis RE, Klepser ME, Pfaller MA. Update on clinical antifungal susceptibility testing for Candida species. Pharmacotherapy. 1998; 18: 509-15.
35. Ruhnke M, Schmidt-Westhausen A, Morschhauser J. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS. J Antimicrob Chemother. 2000; 46: 291-5.
36. Camacho DP, Gasparetto A, Svidzinski TI. The effect of chlorhexidine and gentian violet on the adherence of Candida spp. to urinary catheters. Mycopathologia. 2007; 163: 261-6.
37. White DJ, Johnson EM, Warnock DW. Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata. Genitourin Med. 1993; 69: 112-4.
38. Maccato ML, Kaufman RH. Fungal vulvovaginitis. Curr Opin Obstet Gynecol. 1991; 3: 849-52.
39. Samaranayake YH, Dassanayake RS, Jayatilake JA, et al. Phospholipase B enzyme expression is not associated with other virulence attributes in Candida albicans isolates from patients with human immunodeficiency virus infection. J Med Microbiol. 2005; 54: 583-93.
40. Banno Y, Yamada T, Nozawa Y. Secreted phospholipases of the dimorphic fungus, Candida albicans; separation of three enzymes and some biological properties. Sabouraudia. 1985; 23: 47-54.
41. Mirbod F, Banno Y, Ghannoum MA, et al. Purification and characterization of lysophospholipase-transacylase (h-LPTA) from a highly virulent strain of Candida albicans. Biochim Biophys Acta. 1995; 1257: 181-8.